India’s aviation regulator, the DGCA, orders a one-time drug screening of all commercial pilots by July 2027, citing heightened safety concerns. The decision follows an Air India Phuket–Delhi flight incident on August 4, when the aircraft suddenly loses about 300 feet of altitude, causing injuries among passengers.
According to reports, the pilot-in-command tested positive for illegal drugs after the flight landed. Investigators describe the finding as a serious concern, while authorities have not confirmed whether the pilot’s condition was directly linked to the aircraft’s reported failures, which involved a rare problem with the hydraulic systems and the autopilot disconnecting. The DGCA is consulting airlines and working on draft amendments to existing pilot drug testing rules.
Across outlets, coverage aligns on the regulator’s directive, the timeline (by July 2027), and the grounding in the Air India incident. Differences are mostly in emphasis: some sources detail the testing already underway, while others highlight planned rule changes and international comparisons.